GenMont Biotech (TPE:3164) Cash per Share: NT$4.94 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:3164 GenMont Biotech Inc TPE:3164
86 GF Score
Price NT$15.95
GF Value NT$21.06
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is GenMont Biotech Cash per Share?

GenMont Biotech TPE:3164 -0.31% 86 Cash per Share is NT$4.94 as of Jun. 2026. GuruFocus rates TPE:3164 with a GF Score™ of 86/100 and a GF Value™ of NT$21.06 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). GenMont Biotech's Cash per Share for the quarter that ended in Jun. 2026 was NT$4.94.

GenMont Biotech  (TPE:3164) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

GenMont Biotech Cash per Share Related Terms

GenMont Biotech Cash per Share Historical Data

* Premium members only.

The historical data trend for GenMont Biotech's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMont Biotech Cash per Share Chart

GenMont Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.88 4.64 3.80 4.92 5.03

GenMont Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.13 4.45 5.03 5.31 4.94
TPE:3164
86GF Score
GenMont Biotech Inc TPE:3164
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenMont Biotech Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

GenMont Biotech's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=432.796/86.0
=5.03

GenMont Biotech's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=424.985/86.0
=4.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of NT$4.94 mean?
GenMont Biotech (TPE:3164) has a Cash per Share of NT$4.94 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for GenMont Biotech and its competitors.
Is GenMont Biotech's Cash per Share too high?
GenMont Biotech's current Cash per Share is NT$4.94. Overall, GenMont Biotech has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's Cash per Share compare to VRTX and REGN?
GenMont Biotech's Cash per Share of NT$4.94 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Biotechnology company?
A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for GenMont Biotech and its competitors. GenMont Biotech's current Cash per Share is NT$4.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$21.06, compared to a current price of NT$15.95 — trading 24.3% below its estimated fair value. The current Cash per Share is NT$4.94. GenMont Biotech's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current Cash per Share is NT$4.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GenMont Biotech (TPE:3164) Overvalued in 2026?

Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued. The current stock price of NT$15.95 is trading 24.3% below its estimated GF Value™ of NT$21.06. GuruFocus considers GenMont Biotech to be Modestly Undervalued.

Key valuation signals for TPE:3164:

  • Cash per Share: NT$4.94
  • GF Value™: NT$21.06 vs. price of NT$15.95 (24.3% below fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GenMont Biotech Business Description

Address No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741014
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
86GF Score

Get the complete analysis for TPE:3164

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.95
Price
NT$21.06
GF Value